Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge

De Monte A, Courjon J, Anty R, Cua E, Naqvi A, Mondain V, et al. Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge. J Clin Virol. 2016;78:27-30.

Publication Type:

Journal Article

Authors:

De Monte, Anne; Courjon, Johan; Anty, Rodolphe; Cua, Eric; Naqvi, Alissa; Mondain, Véronique; Cottalorda, Jacqueline; Ollier, Laurence; Giordanengo, Valérie

Source:

J Clin Virol, Volume 78, p.27-30 (2016)

Keywords:

Antiviral Agents, coinfection, HBV reactivation, HCV Direct-Acting Antivirals, Hepatitis B Virus, Hepatitis B, Chronic, Hepatitis C, Chronic, HIV infection, Humans, Male, Middle Aged, NS3/4A protease inhibitors, NS5A inhibitors, NS5B polymerase inhibitors, Protease Inhibitors, Virus Activation

Cited On:

External Third-party Web Link:

https://www.ncbi.nlm.nih.gov/pubmed/26967675

Export Citation:

RIS Format

Top